#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital pseudarthrosis Subdural haematoma Kawasaki's disease Fatty acid oxidation disorder Primary biliary cholangitis Hereditary neuropathic amyloidosis Clear cell papillary renal cell carcinoma Immune-mediated myositis Bladder cancer Philadelphia positive chronic myeloid leukaemia Glycogen storage disease type II Neurodevelopmental disorder Hereditary spastic paraplegia Ehlers-Danlos syndrome Non-Hodgkin's lymphoma unspecified histology aggressive recurrent More trials…

    Learn about Rare Diseases

    Atypical teratoid/rhabdoid tumour of CNS – Basic Information Paroxysmal nocturnal haemoglobinuria – Treatment Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Chondrosarcoma – Basic Information Osteosarcoma recurrent – Trials in Disease Activated PI3 kinase delta syndrome – Diagnostics Retinitis pigmentosa Wolfram syndrome – Life with Disease Alveolar rhabdomyosarcoma – Basic Information Alternating hemiplegia of childhood – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ag-946 Phosphate AGANIRSEN Oxytocin Lutetium (177Lu) Edotreotide Granisetron Camlipixant Magnesium Chloride Hexahydrate Ketoprofen Lysine Ep0031 Cemdisiran Rezvilutamide Pegvaliase Ofloxacin Hydrochloride Sotagliflozin SODIUM BENZOATE Gabapentin Clofarabine LINAPRAZAN GLURATE Pariglasgene Brecaparvovec Lacutamab More therapies…

    Learn about Your Condition

    Carotid artery occlusion Mitral valve prolapse Mucopolysaccharidosis II Tetanus Myelodysplastic syndrome Thrombectomy Post-traumatic headache Cutaneous T-cell lymphoma Peripheral artery thrombosis Transferrin decreased Advanced systemic mastocytosis Nephroblastoma Prodromal Alzheimer's disease Factor VIII deficiency Pyoderma gangrenosum More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Sante et Prevoyance

Sante et Prevoyance

Rue Saint-Luc 8, Namur, 5004, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • A Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis

    Recruiting

    3 1
    Investigated Diseases:
    • Metabolic dysfunction-associated steatohepatitis
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Austria Belgium Bulgaria Czechia France Germany +6

  • Study on Colchicine for Patients with Coronary Artery Disease After Percutaneous Coronary Intervention

    Recruiting

    3 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • Colchicine
    Belgium

  • Study on Preoperative Treatment with mFOLFIRINOX or Gemcitabine-Paclitaxel for Patients with Borderline Resectable Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • ANHYDROUS CALCIUM FOLINATE
    • Irinotecan Hydrochloride Trihydrate
    • Fluorouracil
    Belgium

  • Oral versus intravenous tranexamic acid to reduce bleeding in patients undergoing off‑pump coronary artery bypass surgery

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Coronary artery bypass
    • Coronary artery disease
    Investigated Drugs:
    • Tranexamic Acid
    Belgium

  • Study on Stopping Tenofovir Alafenamide, Tenofovir Disoproxil, and Entecavir in Patients with Chronic Hepatitis B

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • Entecavir
    • Tenofovir Alafenamide
    • Tenofovir Disoproxil
    Belgium

  • Study on Aspirin for Preventing Recurrence and Improving Survival in Patients with Resected Colon Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Placebo
    • Acetylsalicylic Acid
    Belgium

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!